Urology
Spasmex®
Overactive bladder treatment including urinary incontinence
Active ingredient: Trospium chloride 15 / 30 / 45 mg
Available as: Film-coated tablets
Treatment area: Urology: Urinary frequency and incontinence
Package size: 30 / 50 / 100 film-coated tablets
Approval: 1996
Shelf life: 5 years
Climate zones: IVb
Indication: For the symptomatic treatment of increased urinary frequency and / or urinary urgency and / or urinary incontinence in patients with overactive bladder or urodynamically proven idiopathic or neurogenic detrusor overactivity.
Trospium chloride was developed in-house by Dr. Pfleger Arzneimittel and patented in 1963.
Other products
What we do
Our recipe for making perfect products involves three main ingredients: advanced production systems, production in Germany, and a strong commitment to quality.